These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25724578)

  • 1. CD133 marks a stem cell population that drives human primary myelofibrosis.
    Triviai I; Stübig T; Niebuhr B; Hussein K; Tsiftsoglou A; Fehse B; Stocking C; Kröger N
    Haematologica; 2015 Jun; 100(6):768-79. PubMed ID: 25724578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
    Isidori A; Motta MR; Tani M; Terragna C; Zinzani P; Curti A; Rizzi S; Taioli S; Giudice V; D'Addio A; Gugliotta G; Conte R; Baccarani M; Lemoli RM
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1224-32. PubMed ID: 17889360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
    Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
    Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
    Yan D; Pomicter AD; Tantravahi S; Mason CC; Senina AV; Ahmann JM; Wang Q; Than H; Patel AB; Heaton WL; Eiring AM; Clair PM; Gantz KC; Redwine HM; Swierczek SI; Halverson BJ; Baloglu E; Shacham S; Khorashad JS; Kelley TW; Salama ME; Miles RR; Boucher KM; Prchal JT; O'Hare T; Deininger MW
    Clin Cancer Res; 2019 Apr; 25(7):2323-2335. PubMed ID: 30563936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.
    Triviai I; Zeschke S; Rentel J; Spanakis M; Scherer T; Gabdoulline R; Panagiota V; Thol F; Heuser M; Stocking C; Kröger N
    Leukemia; 2019 Jan; 33(1):99-109. PubMed ID: 29907810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of murine JAK2V617F-positive myeloproliferative disease.
    Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
    Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.
    Grundmann F; Scheid C; Braun D; Zobel C; Reuter H; Schwinger RH; Müller-Ehmsen J
    Clin Res Cardiol; 2007 Sep; 96(9):621-7. PubMed ID: 17676354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice.
    Saito N; Yamauchi T; Kawano N; Ono R; Yoshida S; Miyamoto T; Kamimura T; Shultz LD; Saito Y; Takenaka K; Shimoda K; Harada M; Akashi K; Ishikawa F
    Int J Hematol; 2022 Feb; 115(2):198-207. PubMed ID: 34773575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
    Lin EH; Hassan M; Li Y; Zhao H; Nooka A; Sorenson E; Xie K; Champlin R; Wu X; Li D
    Cancer; 2007 Aug; 110(3):534-42. PubMed ID: 17594720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.